Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors (RESIST)

NCT05116137 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT05116137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05116137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors (RESIST)
Lead sponsor
Nova Scotia Health Authority
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 1, 2022
Completion date
December 31, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, glioblastoma multiforme of brain